FDA Investigator Wen Ning Chan (Sally)

Wen Ning Chan (Sally) has conducted inspections on 32 sites in 4 countries as of 11 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
11 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100008937
Countries of Inspections:
Taiwan, United States of America, China, Japan
FDA Investigators that have inspected at least one site in common with Wen Ning Chan (Sally):
Alan M Barker, Alan P Kurtzberg, Allison C Hunter, Andrea A Branche, Andrew J Barrowcliff, Andrew J Lang, Anna M Brannen, Azza Talaat, Bailey A Uetrecht, Bethany L Subel, Brenda C Hamilton, Brigitte K Hofmann, Brittany M Kershaw, Byeongtaek Oh, Carl A Huffman, III, Carl Lee, Chiaochun J Wang, Christina Capacci Daniel, PhD, Christina L Bigham, Christopher T Middendorf, Constantin Y Philopoulos, Cynthia T Cain, D Yvette Barnett, Darren S Morgan, David P Moorhead, David S Jackson, Dell S Moller, Djamila Harouaka, Dorathy M Eischen, Dyvette Arline, Elisa A Nickum, Elizabeth Ll Edwards, Elizabeth P Kinsella, Erika V Butler, Frederick M Lochner, Gam S Zamil, Genevieve E Ghand, German Rivera, Heather A Mccauley, Hugh M Mcclure, II, Jacob G Lutz, James G Marsh, James Norman, James P Mcreavey, Janet L Bowen, Jason C Klein, Javier O Vega, Jazmine N Still, Jennifer L Gustavus, Jennifer L Jager, Jerry J Corwin, Jessica L Pressley, Jill R Loeliger, Jill R Raezer, Jon P Antoniou, Jonathan W Chapman, José E Meléndez, Joshua P Wireman, Joshua S Hunt, Juan Rjimenez Garcia, Junho Pak, Karen M Kondas, Kathleen D Culver, Kenneth E Felkley, Kent C Faul, Kham Phommachanh, Larry K Austin, Lauren N Howard, Lauren N Smith, Lindsey M Schwierjohann, Lisa R Hilliar, Logan T Williams, Lucas B Leake, Luis Mburgos Medero, Lynnsey A Renn, Marcellinus D Dordunoo, Marianne Allen, Maribeth G Grattan, Maribeth G Niesen, Marie F Morin, Mark E Parmon, Mary B Sheets, Mary E Storch, Matt D Suedkamp, Matthew B Casale, Michael A Charles, Michael E Clark, Michael L Casner, Michael P Sheehan, Mra Davism, Nadeem I Chaudhry, Nicholas L Paulin, Nicole E Knowlton, Nina Ni, Noreen Muñiz, Paraluman S Leonin, Paranthaman Senthamaraikannan, Phillip M Pontikos, Pifer, Rafeeq A Habeeb, Robert J Ham, Roy C Stephens, Samuel A Hamblin, Santos E Camara, Scott T Ballard, Shannon A Gregory, Sixto M Mercado Rios, Steven P Eastham, Sydney S Choi, Talmane J Fisher, Tarun D Mehta, Teresa K Kastner, Thomas C Woods, Thomas J Arista, Tiara Nbrown Crosen, Tonia F Bernard, Tracey L Harris, Wayne D Mcgrath, Ying Zhang

Wen Ning Chan (Sally)'s Documents

Publish Date Document Type Title
January, 2022 FDA 483 CIL Isotope Separations, LLC - Form 483, 2022-01-25
August, 2022 FDA 483 Lambda Research Inc - Form 483, 2022-08-26
March, 2022 FDA 483 Camco Chemicals Company Inc - Form 483, 2022-03-02
November, 2022 FDA 483 Chunghwa Chemical Synthesis & Biotech Co., Ltd. - Form 483, 2022-11-18
June, 2021 FDA 483 Response Allergan Sales, LLC - Form 483R, 2021-07-15
January, 2023 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2023-02-02
September, 2023 FDA 483 STELLA CHEMIFA CORPORATION - Form 483, 2023-09-22
January, 2023 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2023-01-11
June, 2021 EIR Allergan Sales, LLC - EIR, 2021-06-24
October, 2022 FDA 483 Haney, Inc. - Form 483, 2022-10-18
March, 2023 FDA 483 Natural Essentials, Inc. - Form 483, 2023-03-10
July, 2023 FDA 483 Church & Dwight Co., Inc. - Form 483, 2023-07-12
December, 2023 FDA 483 Pharmalogic Cincinnati, LLC - Form 483, 2023-12-08
March, 2022 FDA 483 AHC Products Inc - Form 483, 2022-03-29
June, 2021 FDA 483 Allergan Sales, LLC - Form 483, 2021-06-24
July, 2023 EIR Church & Dwight Co., Inc. - EIR, 2023-08-22
June, 2022 FDA 483 Bullet Line, LLC - Form 483, 2022-06-10
February, 2024 FDA 483 Accupack Midwest - Form 483, 2024-02-27
August, 2021 FDA 483 Univar Solutions USA Inc. - Form 483, 2021-08-25
March, 2023 FDA 483 Snf Holdings, LLC - Form 483, 2023-03-02
April, 2023 EIR Patheon Pharmaceuticals Inc. - EIR, 2023-05-11
November, 2021 FDA 483 Best Sanitizers, Inc - Form 483, 2021-11-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more